Update: 04.06.2024
Last week: 21 week 2024 (20.05.2024 - 26.05.2024)
Last full month: April 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 422 | 9.5% | 11.5% | 1.1 | 16 132 146 | 8.3% | 9.4% | 0.8 | -1.1% |
| MoM | 36 442 | 6.8% | 11.5% | 1 | 80 510 850 | 4.8% | 9.7% | 0.8 | -2.7% |
| YTD | 152 122 | 21.4% | 11.1% | 2.4 | 338 978 753 | 49.2% | 9.4% | 2.2 | -5.2% |
| MAT | 367 694 | 31.3% | 10.1% | 1.9 | 768 623 104 | 50.1% | 8.5% | 1.5 | 6.8% |
| BRAINMAX | |||||||||
| WoW | 1 057 | 2.4% | 100.0% | 0 | 3 910 668 | 3.4% | 100.0% | 0 | 2.4% |
| MoM | 5 008 | 6.7% | 100.0% | 0 | 17 994 700 | 5.5% | 100.0% | 0 | 17.9% |
| YTD | 21 486 | 42.2% | 100.0% | 0 | 77 709 495 | 52.6% | 100.0% | 0 | 42.2% |
| MAT | 53 030 | 109.7% | 100.0% | NA | 187 780 075 | 124.4% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 18 314 | -5.0% | 44.1% | 0.4 | 56 923 296 | -4.4% | 35.4% | 0.6 | -5.8% |
| MoM | 79 648 | -0.5% | 45.8% | 1 | 250 870 960 | -0.3% | 37.3% | 1.2 | -2.7% |
| YTD | 360 410 | -1.6% | 44.5% | 1.2 | 1 143 397 113 | 2.9% | 36.3% | -3 | -4.3% |
| MAT | 863 019 | 12.4% | 45.4% | 1.4 | 2 724 300 752 | 20.6% | 38.3% | -0.7 | 9.0% |
| MIGRENIUM | |||||||||
| WoW | 10 362 | -6.5% | 0.5% | 0 | 3 393 323 | -6.6% | 0.7% | 0 | -5.5% |
| MoM | 61 140 | 15.8% | 0.6% | 0.1 | 19 318 134 | 20.2% | 0.9% | 0.2 | -6.0% |
| YTD | 256 836 | 1.0% | 0.6% | -0.1 | 76 671 273 | 67.2% | 0.7% | 0.2 | 15.7% |
| MAT | 644 027 | 6.1% | 0.5% | -0.1 | 153 481 626 | 39.1% | 0.6% | 0 | 17.1% |
| MODELAX-N | |||||||||
| WoW | 25 441 | -3.6% | 20.4% | -0.3 | 11 453 865 | -3.2% | 13.6% | -0.2 | -2.0% |
| MoM | 137 404 | -16.6% | 24.9% | -2.5 | 59 188 675 | -14.0% | 16.3% | -1.2 | -8.3% |
| YTD | 647 433 | 47.4% | 23.4% | 5.1 | 271 229 160 | 96.7% | 14.8% | 4.5 | 15.2% |
| MAT | 1 376 098 | 88.1% | 20.7% | 7.1 | 516 167 799 | 118.3% | 12.3% | 4.5 | 23.4% |
| REDUXIN | |||||||||
| WoW | 14 045 | -6.7% | 33.8% | -0.3 | 75 760 926 | -7.6% | 47.1% | -0.7 | -5.8% |
| MoM | 56 729 | -3.8% | 32.6% | -0.4 | 306 452 225 | -5.6% | 45.6% | -1.1 | -2.7% |
| YTD | 268 634 | -7.2% | 33.2% | -1 | 1 456 970 860 | 21.5% | 46.2% | 3.9 | -4.3% |
| MAT | 617 125 | 1.7% | 32.5% | -2.3 | 3 130 883 510 | 24.9% | 44.1% | 0.7 | 9.0% |
| REDUXIN FORTE | |||||||||
| WoW | 3 522 | -7.3% | 8.5% | -0.1 | 15 563 146 | -5.2% | 9.7% | 0.1 | -5.8% |
| MoM | 15 157 | -2.0% | 8.7% | 0.1 | 64 576 943 | -3.1% | 9.6% | 0 | -2.7% |
| YTD | 70 269 | 4.7% | 8.7% | 0.7 | 306 456 811 | 22.3% | 9.7% | 0.9 | -4.3% |
| MAT | 169 181 | 25.5% | 8.9% | 1.2 | 709 320 270 | 38.9% | 10.0% | 1.2 | 9.0% |
| SALVISAR | |||||||||
| WoW | 11 686 | -5.1% | 1.6% | 0 | 4 934 902 | -5.3% | 1.4% | 0 | -6.6% |
| MoM | 59 234 | 14.4% | 1.7% | 0.2 | 24 423 069 | 19.0% | 1.6% | 0.2 | 1.1% |
| YTD | 224 783 | 1.1% | 1.4% | 0 | 88 679 040 | 23.9% | 1.3% | 0 | 3.7% |
| MAT | 500 851 | -14.0% | 1.2% | -0.3 | 180 827 852 | -8.4% | 1.1% | -0.3 | 8.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 152 122 | 21.4% | 11.1% | 2.4 | 338 978 753 | 49.2% | 9.4% | 2.2 | -5.2% |
| BRAINMAX | 21 486 | 42.2% | 100.0% | 0 | 77 709 495 | 52.6% | 100.0% | 0 | 42.2% |
| GOLDLINE PLUS | 360 410 | -1.6% | 44.5% | 1.2 | 1 143 397 113 | 2.9% | 36.3% | -3 | -4.3% |
| MIGRENIUM | 256 836 | 1.0% | 0.6% | -0.1 | 76 671 273 | 67.2% | 0.7% | 0.2 | 15.7% |
| MODELAX-N | 647 433 | 47.4% | 23.4% | 5.1 | 271 229 160 | 96.7% | 14.8% | 4.5 | 15.2% |
| REDUXIN CAPS | 268 634 | -7.2% | 33.2% | -1 | 1 456 970 860 | 21.5% | 46.2% | 3.9 | -4.3% |
| REDUXIN FORTE | 70 269 | 4.7% | 8.7% | 0.7 | 306 456 811 | 22.3% | 9.7% | 0.9 | -4.3% |
| SALVISAR | 224 783 | 1.1% | 1.4% | 0 | 88 679 040 | 23.9% | 1.3% | 0 | 3.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 367 694 | 31.3% | 10.1% | 1.9 | 768 623 104 | 50.1% | 8.5% | 1.5 | 6.8% |
| BRAINMAX | 53 030 | 109.7% | 100.0% | NA | 187 780 075 | 124.4% | 100.0% | NA | NA |
| GOLDLINE PLUS | 863 019 | 12.4% | 45.4% | 1.4 | 2 724 300 752 | 20.6% | 38.3% | -0.7 | 9.0% |
| MIGRENIUM | 644 027 | 6.1% | 0.5% | -0.1 | 153 481 626 | 39.1% | 0.6% | 0 | 17.1% |
| MODELAX-N | 1 376 098 | 88.1% | 20.7% | 7.1 | 516 167 799 | 118.3% | 12.3% | 4.5 | 23.4% |
| REDUXIN CAPS | 617 125 | 1.7% | 32.5% | -2.3 | 3 130 883 510 | 24.9% | 44.1% | 0.7 | 9.0% |
| REDUXIN FORTE | 169 181 | 25.5% | 8.9% | 1.2 | 709 320 270 | 38.9% | 10.0% | 1.2 | 9.0% |
| SALVISAR | 500 851 | -14.0% | 1.2% | -0.3 | 180 827 852 | -8.4% | 1.1% | -0.3 | 8.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 422 | 9.5% | 11.5% | 1.1 | 16 132 146 | 8.3% | 9.4% | 0.8 | -1.1% |
| BRAINMAX | 1 057 | 2.4% | 100.0% | 0 | 3 910 668 | 3.4% | 100.0% | 0 | 2.4% |
| GOLDLINE PLUS | 18 314 | -5.0% | 44.1% | 0.4 | 56 923 296 | -4.4% | 35.4% | 0.6 | -5.8% |
| MIGRENIUM | 10 362 | -6.5% | 0.5% | 0 | 3 393 323 | -6.6% | 0.7% | 0 | -5.5% |
| MODELAX-N | 25 441 | -3.6% | 20.4% | -0.3 | 11 453 865 | -3.2% | 13.6% | -0.2 | -2.0% |
| REDUXIN CAPS | 14 045 | -6.7% | 33.8% | -0.3 | 75 760 926 | -7.6% | 47.1% | -0.7 | -5.8% |
| REDUXIN FORTE | 3 522 | -7.3% | 8.5% | -0.1 | 15 563 146 | -5.2% | 9.7% | 0.1 | -5.8% |
| SALVISAR | 11 686 | -5.1% | 1.6% | 0 | 4 934 902 | -5.3% | 1.4% | 0 | -6.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 36 442 | 6.8% | 11.5% | 1 | 80 510 850 | 4.8% | 9.7% | 0.8 | -2.7% |
| BRAINMAX | 5 008 | 6.7% | 100.0% | 0 | 17 994 700 | 5.5% | 100.0% | 0 | 17.9% |
| GOLDLINE PLUS | 79 648 | -0.5% | 45.8% | 1 | 250 870 960 | -0.3% | 37.3% | 1.2 | -2.7% |
| MIGRENIUM | 61 140 | 15.8% | 0.6% | 0.1 | 19 318 134 | 20.2% | 0.9% | 0.2 | -6.0% |
| MODELAX-N | 137 404 | -16.6% | 24.9% | -2.5 | 59 188 675 | -14.0% | 16.3% | -1.2 | -8.3% |
| REDUXIN CAPS | 56 729 | -3.8% | 32.6% | -0.4 | 306 452 225 | -5.6% | 45.6% | -1.1 | -2.7% |
| REDUXIN FORTE | 15 157 | -2.0% | 8.7% | 0.1 | 64 576 943 | -3.1% | 9.6% | 0 | -2.7% |
| SALVISAR | 59 234 | 14.4% | 1.7% | 0.2 | 24 423 069 | 19.0% | 1.6% | 0.2 | 1.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"## [1] "MODELAX-N"## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"## [1] "AMBENE BIO"## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"## [1] "AMBENE BIO"## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"## [1] "MIGRENIUM"## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"## [1] "MIGRENIUM"## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"## [1] "SALVISAR"## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"## [1] "SALVISAR"## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"## [1] "REDUXIN CAPS"## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"## [1] "REDUXIN CAPS"## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"## [1] "REDUXIN FORTE"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"## [1] "REDUXIN FORTE"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"## [1] "GOLDLINE PLUS"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"## [1] "GOLDLINE PLUS"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"## [1] "BRAINMAX CAPS 250 MG+250 MG #40"## [1] "BRAINMAX CAPS 250 MG+250 MG #60"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"## [1] "BRAINMAX"## [1] "BRAINMAX CAPS 250 MG+250 MG #40"## [1] "BRAINMAX CAPS 250 MG+250 MG #60"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs